# 119-hr-4101: Cancer Drug Parity Act of 2025

119-hr-4101, Cancer Drug Parity Act of 2025, is a 119th Congress bill sponsored by Rep. Grothman, Glenn [R-WI-6] (R-WI); status introduced; PRIA reads it as touching household money (as of 2026-10-11).

- Canonical: https://policyrisk.com/legislation/119-hr-4101
- As of: 2026-10-11
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Bill: 119-hr-4101
- Congress: 119
- Title: Cancer Drug Parity Act of 2025
- Status: introduced
- Introduced: 2025-06-24
- Sponsor: Rep. Grothman, Glenn [R-WI-6] (R-WI)
- Cosponsors: 31
- Policy area: Health
- Touches household money: yes
- Last recorded action: 2026-10-11

## Summary

**Parity in cost-sharing for FDA‑approved oral anticancer medications.** This bill would require group health plans to ensure cost-sharing for prescribed, patient‑administered oral anticancer drugs is no less favorable than cost-sharing for anticancer drugs given intravenously or by injection. - Patients and families: Would make copayments, coinsurance, deductibles, and similar out-of-pocket limits for oral anticancer drugs at least as favorable as for IV or injected cancer treatments. This change applies to plan years beginning on or after January 1, 2026. - Employers and insurers: Could not raise out-of-pocket costs, reclassify benefits to increase costs, or apply more restrictive limits to oral anticancer drugs to comply. Plans may still use prior authorization and other appropriate utilization controls consistent with existing law. - Policymakers and researchers: Directs the Government Accountability Office to study the law's impact on out-of-pocket costs for covered group health plan enrollees and to report findings and recommendations within 2 years after enactment.

## Cosponsors (31)

- Rep. Pocan, Mark [D-WI-2] (D-WI), 2026-10-09T00:00:00.000Z
- Rep. Pingree, Chellie [D-ME-1] (D-ME), 2026-10-09T00:00:00.000Z
- Rep. Bonamici, Suzanne [D-OR-1] (D-OR), 2025-06-24T00:00:00.000Z
- Rep. Bilirakis, Gus M. [R-FL-12] (R-FL), 2025-06-24T00:00:00.000Z
- Rep. Fitzpatrick, Brian K. [R-PA-1] (R-PA), 2025-06-24T00:00:00.000Z
- Rep. Morelle, Joseph D. [D-NY-25] (D-NY), 2025-06-24T00:00:00.000Z
- Rep. Matsui, Doris O. [D-CA-7] (D-CA), 2025-06-24T00:00:00.000Z
- Rep. Brownley, Julia [D-CA-26] (D-CA), 2025-06-24T00:00:00.000Z
- Rep. Moore, Gwen [D-WI-4] (D-WI), 2025-06-24T00:00:00.000Z
- Rep. Davis, Donald G. [D-NC-1] (D-NC), 2025-06-24T00:00:00.000Z
- Rep. Davids, Sharice [D-KS-3] (D-KS), 2025-06-24T00:00:00.000Z
- Rep. Wilson, Joe [R-SC-2] (R-SC), 2025-06-24T00:00:00.000Z
- Rep. Kennedy, Timothy M. [D-NY-26] (D-NY), 2025-06-25T00:00:00.000Z
- Rep. Castor, Kathy [D-FL-14] (D-FL), 2025-06-25T00:00:00.000Z
- Rep. Raskin, Jamie [D-MD-8] (D-MD), 2025-09-09T00:00:00.000Z
- Del. Norton, Eleanor Holmes [D-DC-At Large] (D-DC), 2025-09-15T00:00:00.000Z
- Rep. Balint, Becca [D-VT-At Large] (D-VT), 2025-09-15T00:00:00.000Z
- Rep. Bresnahan, Robert P. [R-PA-8] (R-PA), 2025-09-30T00:00:00.000Z
- Rep. Vindman, Eugene Simon [D-VA-7] (D-VA), 2025-10-03T00:00:00.000Z
- Rep. Ross, Deborah K. [D-NC-2] (D-NC), 2025-10-08T00:00:00.000Z
- Rep. Garamendi, John [D-CA-8] (D-CA), 2025-10-17T00:00:00.000Z
- Rep. Houlahan, Chrissy [D-PA-6] (D-PA), 2025-10-21T00:00:00.000Z
- Rep. Jackson, Jonathan L. [D-IL-1] (D-IL), 2025-10-24T00:00:00.000Z
- Rep. Conaway, Herbert C. [D-NJ-3] (D-NJ), 2025-11-07T00:00:00.000Z
- Rep. Salinas, Andrea [D-OR-6] (D-OR), 2025-11-07T00:00:00.000Z
- Rep. Bynum, Janelle S. [D-OR-5] (D-OR), 2025-11-07T00:00:00.000Z
- Rep. Neguse, Joe [D-CO-2] (D-CO), 2025-12-18T00:00:00.000Z
- Rep. Pappas, Chris [D-NH-1] (D-NH), 2025-12-18T00:00:00.000Z
- Rep. Schmidt, Derek [R-KS-2] (R-KS), 2026-03-16T00:00:00.000Z
- Rep. Case, Ed [D-HI-1] (D-HI), 2026-07-27T00:00:00.000Z
- Rep. Keating, William R. [D-MA-9] (D-MA), 2026-08-20T00:00:00.000Z

## Provisions PRIA read

- Equal costs for oral cancer pills in job-based plans: benefit, high. If enacted, job-based health plans would match cost-sharing for oral cancer pills to IV or injected chemo. This would apply only to FDA-approved, patient-administered drugs your doctor finds medically necessary or clinically appropriate. Plans could still use prior authorization, and stronger state…

## Related bills

- 119-hr-3514: Improving Seniors’ Timely Access to Care Act of 2025
- 119-hr-1262: Mikaela Naylon Give Kids a Chance Act
- 119-hr-3277: Ensuring Lasting Smiles Act
- 119-hr-842: Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
- 119-hr-2102: Major Richard Star Act
- 119-hr-979: AM Radio for Every Vehicle Act of 2025

## Sources
- [119-hr-4101 on Congress.gov](https://www.congress.gov/bill/119th-congress/house-bill/4101)

## Related
- [119-hr-3514: Improving Seniors’ Timely Access to Care Act of 2025](https://policyrisk.com/legislation/119-hr-3514)
- [119-hr-1262: Mikaela Naylon Give Kids a Chance Act](https://policyrisk.com/legislation/119-hr-1262)
- [119-hr-3277: Ensuring Lasting Smiles Act](https://policyrisk.com/legislation/119-hr-3277)
- [119-hr-842: Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage A…](https://policyrisk.com/legislation/119-hr-842)
- [119-hr-2102: Major Richard Star Act](https://policyrisk.com/legislation/119-hr-2102)
- [119-hr-979: AM Radio for Every Vehicle Act of 2025](https://policyrisk.com/legislation/119-hr-979)
- [All bills in Congress](https://policyrisk.com/legislation)

Source: PRIA, https://policyrisk.com/legislation/119-hr-4101 (as of 2026-10-11).